These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2514091)

  • 1. TRH-induced reflex changes in patients with ALS.
    Hawley RJ; Sirdofsky M; Kratz R
    Electromyogr Clin Neurophysiol; 1989; 29(7-8):465-7. PubMed ID: 2514091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spinal mechanism of the antispastic action of TRH in patients with amyotrophic lateral sclerosis].
    Morin C; Pierrot-Deseilligny E
    Rev Neurol (Paris); 1988; 144(11):701-3. PubMed ID: 3148185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].
    Serratrice G; Desnuelle C; Crevat A; Guelton C; Meyer-Dutour A
    Rev Neurol (Paris); 1986; 142(2):133-9. PubMed ID: 3088700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous thyrotropin-releasing hormone in patients with amyotrophic lateral sclerosis. Dose-response and randomized concurrent placebo-controlled pilot studies.
    Brooks BR; Sufit RL; Montgomery GK; Beaulieu DA; Erickson LM
    Neurol Clin; 1987 Feb; 5(1):143-58. PubMed ID: 3104750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis.
    de Carvalho M; Scotto M; Lopes A; Swash M
    Muscle Nerve; 2003 Nov; 28(5):630-3. PubMed ID: 14571468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of amyotrophic lateral sclerosis with disturbance of vertical ocular movement responding to thyrotropin releasing hormone (TRH)].
    Nemoto H; Yoshimura M; Kurihara T; Kinoshita M
    Rinsho Shinkeigaku; 1991 Jan; 31(1):84-6. PubMed ID: 1904337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudomotor dysfunction in amyotrophic lateral sclerosis.
    Kihara M; Takahashi A; Sugenoya J; Kihara Y; Watanabe H
    Funct Neurol; 1994; 9(4):193-7. PubMed ID: 7883205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single fiber electromyography in 78 patients with amyotrophic lateral sclerosis.
    Cui LY; Liu MS; Tang XF
    Chin Med J (Engl); 2004 Dec; 117(12):1830-3. PubMed ID: 15603713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials.
    Mitsumoto H; Salgado ED; Negroski D; Hanson MR; Salanga VD; Wilber JF; Wilbourn AJ; Breuer AC; Leatherman J
    Neurology; 1986 Feb; 36(2):152-9. PubMed ID: 3080695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor unit number estimation, isometric strength, and electromyographic measures in amyotrophic lateral sclerosis.
    Bromberg MB; Forshew DA; Nau KL; Bromberg J; Simmons Z; Fries TJ
    Muscle Nerve; 1993 Nov; 16(11):1213-9. PubMed ID: 8413373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [State of mechanisms regulating muscle tone in amyotrophic lateral sclerosis (clinico-electromyographic study)].
    Zavalishin IA; Novikova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):37-42. PubMed ID: 6858495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of amyotrophic lateral sclerosis with the TRH analog DN-1417.
    Hawley RJ; Kratz R; Goodman RR; McCutchen CB; Sirdofsky M; Hanson PA
    Neurology; 1987 Apr; 37(4):715-7. PubMed ID: 3104820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loss of voluntary control and retention of automatic reflex in certain muscles innervated by cranial nerves in 2 cases of amyotrophic lateral sclerosis].
    Lapresle J; Salisachs P
    Rev Neurol (Paris); 1976 Feb; 132(2):157-61. PubMed ID: 973070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Brooke MH; Florence JM; Heller SL; Kaiser KK; Phillips D; Gruber A; Babcock D; Miller JP
    Neurology; 1986 Feb; 36(2):146-51. PubMed ID: 3080694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of amyotrophic lateral sclerosis with TRH].
    Klimek A; Szulc-Kuberska J; Czernielewska-Rutkowska I; Głuszcz-Zielińska A
    Neurol Neurochir Pol; 1988; 22(3):206-10. PubMed ID: 3146705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromyography in amyotrophic lateral sclerosis. A review.
    Marinacci AA; VonHagen KO
    Bull Los Angeles Neurol Soc; 1974 Jan; 39(1):17-29. PubMed ID: 4811862
    [No Abstract]   [Full Text] [Related]  

  • 18. F-Waves and the corticospinal lesion in amyotrophic lateral sclerosis.
    de Carvalho M; Scotto M; Lopes A; Swash M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep; 3(3):131-6. PubMed ID: 12495574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A summary of the current position of TRH in ALS therapy.
    Brooks BR
    Ann N Y Acad Sci; 1989; 553():431-61. PubMed ID: 2497685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.